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882-2 Left Ventricular Function and Long-Term Right 
Ventricular Pacing in Patients With Atrial Fibrillation 
Following Atrioventricular Node Ablation 
Cevher Ozcan, Paul A. Friedman, David 0. Hodge, Bernard J. Gersh, David L. Hayes, 
Stephen C. Hammill, Win K. Shen, Mayo Clinic, Rochester, MN 
Background: Although atrioventricular node (AVN) ablation and permanent pacing (PM) 
is effective in treating patients (pts) with refractory atrial fibrillation (AF). The Impact of 
long-term right ventricular pacing, resulting in asynchronous contraction, on left ventricu- 
lar ejection fraction (EF) and survival in pts with normal EF at baseline remains unclear. 
Methods: The study group included 50 consecutive pts with EF >50% who underwent 
AVN ablation and PM implantation. Patients with a history of myocardial Infarction and 
dilated cardtomyopathy were excluded. The EF was estimated by echo before and after 
ablation. Observed survival was estimated by Kaplan-Meier method and compared with 
age- and gender- matched expected survival. Predictors for suwival were assessed by 
cox model. 
Results: Of the 50 study cohorts (mean age 68+/-10 years, 13 male), a single (44%) or 
dual (56%) chamber PM was implanted following AVN ablation. Left ventricular EF was 
62+/-7% and 59+/-10% (p>O.O5) before and after ablation, respectively. The EF 
decreased in 20 pts (40%). increased in 19 pts (38%) and remained unchanged in 11 pts 
(22%) during 19+/-20 months of follow-up. The majority of the changes in EF were less 
than 10%. Among pts with a decreased EF, the decrease was >lO% in 8 pts (16%). 
Mitral (p=O.O29) and aortic (p=O.O49) stenosis were predictors of the decrease in EF. The 
observed survival in the study population (50 pts) was similar with the expected survival 
from age- and gender-matched controls (p=O.l7). However, survival in the 8 pts with a 
reduction in EF (>lO%) was significantly wxse than the expected survival (pcO.001) and 
the observed survival from the rest of the study cohorts. The observed suwival of the 
later group was comparable to the expected surwal (p=O.67). 
Conclusion: In pts with normal EF at baseline, a stgniflcant reduction @IO%) in EF was 
observed in a subset (16%) of pts undergoing AVN ablation and conventional right ven- 
tricular apical pacing for the treatment of symptomatic AF. Although the causes of EF 
reduction can not be determined from the current study, predictors such es valvular 
stenosis raise a potential association of diastolic dysfunction and decrease in EF in this 
pt population. 
1 I:00 a.m. 
882-3 A Novel Approach to Achieve Regular Ventricular 
Pacing at Desired Slow Rate During Atrial Fibrillation 
Without Atrioventricular Nodal Ablation: Application of 
Selective Atrioventricular Nodal Vagal Stimulation 
Youhua Zhanq. Kent A. Mowrey, Shaowei Zhuang, Todor N. Mazgalev, The Cleveland 
Clinic Foundation, Cleveland, OH 
Background: A novel strategy, selective atrioventricular nodal (AVN) vagal stimulation 
(AVN-VS), can be used to slow the ventricular rate (VR) during atrlal fibrillation (AF). 
However, with this technique, the VR remains irregular. On the other hand, it is known 
that ventricular on-demand (VVI) pacing can achieve rate regularization, but only at fast 
rates that equal the intrinsic rate during AF. We hypothesized that AVN-VS combined 
with VVI pacing could achieve a slow, regular rate during AF. 
Methods: AF was induced in 6 dogs by rapid atrial pacing. AVN-VS was applied to the 
eplcardial fat pad that projects vagal fibers to the AVN. A computer controlled algorithm 
adjusted AVN-VS to achieve a mean ventricular RR interval of 75%, 1 OO%, or 125% of 
the spontaneous smus cycle length @CL). After the targets were achieved, concomitant 
VVI pacing was delivered at a cycle length equal to the corresponding mean VR. 
Results: AF resulted in a rapid, irregular VR (figure, beats l-500, RR=298+70ms). AVN- 
VS slowed the VR (beats 501-1000, RR=500*14lms). In the presence of AVN-VS, con- 
comitant VVI pacing eliminated irregularity (beats 1501-2000, RR=500+0ms). Similar 
results were achieved in all animals at each of the 3 target rates (average RR with AVN- 
VS was 381+62ms, 508+78ms and 632+96ms, respectively; with AVN-VS+VVI pacing 
was 381+0ms, 508rOms and 632_tOms, respectively). 
Conclusions: A novel approach combining AVN-VS with VVI pacing results in a desired 
slow, regular VR during AF that does not necessitate AVN ablation. 
11:15 a.m. 
882-4 Feasibility of His Bundle Pacing Guided by Intracardiac 
Echocardiography 
Raveen R. Bazaz David Euler, David Schwartzman, Atrial Arrhythmia Center, University’ 
of Pittsburgh, Plttsburgh, PA, Medtronic, Inc., Minneapolis, MN 
Background: Recent data have suggested that pacing from standard sites such es the 
right ventricular (RV) apex can promote the development of left ventricular dysfunction; 
this is presumed to result from aberrant activation. Prior reports have shown that ventric- 
ular capture mediated by His Bundle pacing (HBP) eliminates the aberrancy. However, 
using fluoroscopic guidance, HBP is extremely difficult, thus limiting its application. We 
hypothesized that intracardiac echocardiography (ICE) could be used to facilitate HBP. 
Our goal in this initial study was to demonstrate the feasibility of this concept and gain 
better insight into the correlation between endocardial anatomy and electrophysiology. 
Methods: Ten consecutive patients with persistent atrial fibrillation underwent AV node 
ablation. Ablation was guided by ICE (9 MHz; Boston Scientific), targeting the compact 
AV node. After ablation, the distal electrode (2 mm length) of a standard deflectable cath- 
eterwas guided by ICE to sites distal to the ablation site. where unipolar pacing was per- 
formed. At each site, a standard 12-&d ECG was obtamed at capture threshold (2 msec 
pulse width, constant current pulses).Results: ICE prowded a detalled view of the mem- 
branous interventricular septum (MS). On the atrial side of the atrloventricular junction 
(AVJ), pacing at the MS resulted in “pure” HB capture (defined by a pacing stimulus-V 
interval approximating the pre-ablation HB-V interval and ECG identical to pre-ablation; 
median threshold 4 mA). Pacing at the MS on the ventricular side of the AVJ at high out- 
puts (median threshold 14 mA) resulted in “hybrid” HB capture (HB and RV basal septal 
myocardium captured simultaneously); at lower outputs, HB capture was lost, leaving 
only RV basal septal capture (median threshold 1 mA). In each pattent, there were signif- 
icant dlfferences in electrocardiographic QRS duration: pure < hybrld+HB < hybrid-HE < 
RV apex. Conclusions: The electrophysiologic manifestations of pacing were consis- 
tently linked to endocardial anatomy es defined by ICE. Guided by ICE, pure and hybrid 
HBP could be achieved reproducibly. The data suggest that en ICE-guided technique for 
permanent HBP may be worth further investigation. 
11:30 a.m. 
882-5 Therapy of Malignant Vasovagal Syncope With Closed 
Loop Pacemaker Stimulation 
Lothar Griesbach, Thomas Huber, BBrbel Knote, Jens H&&l. Heinrich Reinke, District 
General Hospital, Kirchberg, Germany 
Background: Vasovagal syncope (VVS) is often preceded by a sympathetic tone varia- 
tion and is accompanied with a drop in heart rate and bradycardia. Since Closed Loop 
Stimulation (CLS) pacemakers modulate the pacing rate according to the contraction 
dynamics of the right ventricle, CLS may interfere with the onset mechanism of VVS and 
prevent fainting. 
Methods: We implanted the In& CLS pacemaker (Biotronik. Germany) in 20 patients 
(pts) with VVS refractory to conventional p -blocker therapy. The mean age of the pts 
was 62.5 f 15.5 years; 80% were female. During the pre-implantation head-up tilt test 
(HUTT), the VVS was categorized es cardloinhlbitoty type 2A (n=16) or 28 (n=l), or 
vasodepressor type 3 (n=3). The HUTT consisted of the supme position for IO min, 2-3 
jets of the nitrolingual-spray. and the 60” tilt for 15 ml”. During a repeated HUTT at > 1 
week after pacemaker implantation, with CLS activated, the patient’s heart rate was con- 
tinuously monitored and blood pressure periodically recorded. The pts were followed for 
syncopal events in daily life for 14.6 r 30.9 months after pacemaker implantation. 
Results: The post-implantation HUT triggered an increase in pacing rate in all 20 pts. 
Twelve pts (11 pts with VVS type 2A and one patient with VVS type 2B) were symptom 
free during HUT. The remaining 8 pts experienced pre-syncope (3 pts with VVS type 3, 
and 5 pts who converted from VVS type 2A to type 3 dunng CLS pacing). None of the 20 
pts reporied on VVS during daily life after pacemaker implantation, and all had Improved 
quality of life. 
Conclusions: In pts refractory to p-blocker treatment, pacemaker therapy can prevent 
syncope. The studied pacemaker provided elevated heart rate during HUTT, likely due to 
contractility changes that precede VVS. According to the HUTT results and the long-term 
follow-up after pacemaker implantation, CLS seems to be effective in the prevention of 
VVS types 2A or 28. In pts with VVS type 3, pacing may alleviate the symptoms and 
extend the prodromal phase but cannot completely eliminate VVS. 
11:45 a.m. 
882-6 Clinical Benefit and Technical Accuracy Evaluation of 
Wireless Home Monitoring Pacemaker System: 
Multicenter Clinical Trial Data 
Suna H. Chun, Karen J. Friday, Antonio Ghan. L. B. Liem. Stanford University School of 
Medicine, Stanford, CA, Chanwell Clinic, San Jose, CA 
BACKGROUND: Newly developed telecare technology allows wireless communication 
between pacemakers (PPM) and physicians (MD). This can establish closer PPM follow 
up (f/u) es well es more accurate monitoring of patient’s (pt) arrhythmia status. METHOD: 
To test whether wireless communication technology between PPMs and MDs can pro- 
vide accurate information and clinical benefit, Home monitoring PPM system by 
Biotronik, Inc. was evaluated. Each transmission from pt’s PPM to MDs was assessed for 
technical accuracy, timeliness. and clinical benefit. Following MDs assessed each trans- 
mission for Its ckn~cal benefit. RESULTS: 105 pts underwent implantation es of August 
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31, 2002; 84 pts completed 90 day f/u. 8228 transmissions were completed among these 
pts. Transmission success rate was 92.8% with median transmission time of 1 minute 29 
seconds. 60 random transmissions were audited for accuracy. Each transmission 
included 15 parameters, e.g. mean heart rate, Premature Ventricular Contraction cou- 
plets, triplets, etc. Therefore, total of 900 parameters were included in this 60 transmis- 
sions audited. Data accuracy with this audit was 100%. Among 84 pts with complete flu, 
direct clinical benefit using wireless technology was documented in 40 pts (48%). These 
clinical benefits reported by following MDs included detection of lead dislodgement (3 
pts), onset of atrial fibrillation detection (4 pts), detection of SVT and VT within 24 hours 
of occurrence (4 pts), antiarrhythmic medication monitoring (4 pts). atrial and ventricular 
undersensing detection (4 pts). PPM program optimization. i.e. AV delay optimization, 
rate responsiveness adjustment (16 pts), and other findings leading to bolter or electro- 
physiologic study (3 pts). Effective monitoring of pts in remote areas and in nursing 
homes was also achieved. CONCLUSION: This study result demonstrates clinical bene- 
fit using wireless communication between PPMs and MDs. 48% of pts received clinical 
benefits during 90 day flu. Wireless Home monitoring system is highly accurate and 
promptly delivers data from pt’s PPM to MD’s office. Telecare achieved by wireless home 
monitoring system can optimize PPM and arrhythmia management. 
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